John Johnson, via W20
Melinta chief John Johnson jumps ship — with the chairman — from another troubled antibiotics play
Just 9 months after taking the reins at Melinta, the experienced biotech exec John Johnson is whirling back out through the revolving door to the C suite at the troubled antibiotics company.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
